Professor
at University College London
Dame Ijeoma Uchegbu is a professor of pharmaceutical nanoscience at University College London, president of the Wolfson College at the University of Cambridge and CSO at Nanomerics. Uchegbu has studied drug transport mechanisms across biological barriers and created transformational drug transport nanoparticles. She was the first to show that peptides could be delivered across the blood-brain barrier to elicit a pharmacological response when presented as peptide drug nanofibers. She was also the first to demonstrate, via definitive pharmacology and pharmacokinetics evidence, peptide transport into the brain, using peptide nanoparticles delivered via the nose-to-brain route. Uchegbu has also won numerous prizes for her work and these include: the UK Government's Women of Outstanding Achievement in Science, Engineering and Technology 2007, Royal Pharmaceutical Society Pharmaceutical Scientist of the Year 2012, Special Recognition Business of Science Leadership Award 2023. In 2019, she received an honorary degree from Lincoln University and in 2024, she received honorary degrees from both the University of West London and Sheffield Hallam University. In 2024 Uchegbu was listed in Who's Who 2024. Uchegbu was made a Dame Commander of the Most Excellent Order of the British Empire in the 2025 New Year Honours.
Education
Awards & Certifications
UK Government's Women of Outstanding Achievement in Science, Engineering and Technology 2007
Royal Pharmaceutical Society Pharmaceutical Scientist of the Year 2012
Special Recognition Business of Science Leadership Award 2023
Dame Commander of the Most Excellent Order of the British Empire in the 2025 New Year Honours
Accreditations
Fellow recognised by The Academy of Medical Sciences
Honorary Fellow recognised by The Royal Society of Chemistry
Honorary Fellow recognised by The British Pharmacological Society
Fellow recognised by The Royal Society of Biology
Areas of Expertise
Got a Question for Ijeoma Uchegbu, PhD, DBE?
Get in touch using the contact form linked here and we'll get back to you shortly.